Novel casein protein product

ABSTRACT

The present invention relates to a process for producing a casein protein product comprising the steps of: providing a casein concentrate starting material; heat-treating the material; cooling the heat-treated material; subjecting the cooled material to a treatment with a crosslinking enzyme; optionally subjecting the cooled material to a treatment with a coagulant; and processing the material into the casein protein product/allowing the casein protein product to form.

This application is a divisional of U.S. application Ser. No.14/409,904, filed Dec. 19, 2014, which is the U.S. National Phase ofInternational Application No. PCT/FI2013/050705 filed Jun. 26, 2013which designated the U.S. and claims priority to FI 20125735 filed Jun.27, 2012, the entire contents of each of which are hereby incorporatedby reference.

FIELD OF THE INVENTION

The invention relates to a method for preparing a casein proteinproduct. Further, the invention relates to a casein protein productcomprising casein, lactose, calcium, phosphorus and biologically activepeptides.

BACKGROUND OF THE INVENTION

Raw milk contains in addition to water (about 87%), fat (about 4.5%),lactose (about 5%) and protein (about 3.3%) also minerals and traceelements, such as calcium, magnesium, phosphorus, manganese, potassium,sodium, iodine and zinc. Further, milk contains also vitamins, such asA, K, B12, B6 and B2. The amino acid composition of milk proteins hasbetter biological value than any other protein (red or white meat). Milkproteins contain a lot of so-called essential amino acids like lysine,leucine and isoleucine. The proteins of milk belong to casein or wheyproteins. Typically the ratio of casein protein to whey protein in cow'smilk is about 80:20. The major whey proteins in milk arebeta-lactoglobulin and alpha-lactalbumin having molecular sizes of 14-18kDa. Casein make up about 80% of the proteins in cow milk and aredivided into alpha- , beta- and kappa-caseins. The molecular sizes ofcaseins are in the range of 19-23 kDa. In milk, casein exists in groupsof molecules that are called micelles. These particles/micelles consistof casein, calcium, inorganic phosphate and citrate ions. In one caseinparticle there are about 20 000 single casein protein molecules. Caseinparticle has a porous structure containing water about 3 g per 1 g ofcasein.

Amino acids of animal- and plant-based proteins may be cross-linked byenzymes, such as transglutaminase, laccase, tyrosinase, peroxidase,sulfhydryl oxidase and protein glutaminase in a known manner. Thetransglutaminase enzyme (EC 2.3.2.13) catalyzes the generation ofcovalent linkages between the glutamine and lysine amino acid residuespresent in the protein molecules. When linkages are formed, ammonia isreleased. The enzyme was first used in Japan in the manufacture ofsurimi (seafish paste) products (Kuraishi, et. al., Food Rev. Int.17(2), 2001, pp. 221 to 246). Covalent bonds formed in the enzymetreatment withstand different process conditions, such as heating andmixing, well. From milk proteins, caseins and particularly theκ-caseins, are the best substrate for transglutaminase. δ-casein is alsorich in glutamine and lysine, which are linked together bytransglutaminase.

It is known that milk contains substances that inhibit the activity oftransglutaminase. These inhibiting substances are deactivated in a heattreatment of milk. On the other hand, it is known that the content ofsaid substances in relation to the total content of proteins and fat isreduced in ultrafiltration of milk.

Meat analogs based on plant proteins, especially soy proteins arecommercially available. In recent years methods for preparing meatanalogs from milk and egg proteins in addition to plant proteins havebeen developed and such processes are described in the patentpublications EP 1467628 B1, EP 1588626 B1, EP 1643850 B1 and EP 1772060B1, for example.

BRIEF DESCRIPTION OF THE INVENTION

The present invention relates to a process for producing a caseinprotein product having microstructure similar type to a meat analogue,comprising the steps of:

-   -   a) providing a casein concentrate starting material    -   b) optionally concentrating the casein concentrate material    -   c) heat-treating the material    -   d) cooling the heat-treated material    -   e) subjecting the cooled material to a treatment with a        crosslinking enzyme    -   f) optionally subjecting the cooled material to a treatment with        a coagulant    -   g) processing the material into the casein protein        product/allowing the casein protein product to form    -   h) optionally collecting and/or packing the product.

The present invention relates also to a casein protein productcomprising milk proteins from about 9 to about 50 weight-%, of whichabout 8.5 to about 50 weight-% are casein proteins, lactose 0 to about2%, calcium from about 1300 mg/kg to about 12500 mg/kg, phosphorus about1600 to about 8000 mg/kg and optionally biologically active peptides(tripeptides IPP and/or VPP) from about 20 to about 700 mg/kg. In oneembodiment, the product comprises milk proteins from about 15 to about30 weight-%, of which about 14.5 to about 30 weight-% are caseinproteins. In another embodiment, the casein protein product comprisescalcium from about 4000 to about 7000 mg/kg.

The objects of the invention are achieved by methods and productscharacterized by what is stated in the independent claims. The preferredembodiments of the invention are disclosed in the dependent claims.

DETAILED DESCRIPTION OF THE INVENTION

There is currently a continuous need for meat substituting proteinproducts in the market. The present invention is based on the findingthat treating a casein concentrate material with a crosslinking enzymeand optionally with a coagulant produces a casein protein product havingmicrostructure similar to a meat analogue. Accordingly, the inventionrelates to a process for producing a casein protein product, comprisingthe steps of:

-   -   a) providing a casein concentrate starting material,    -   b) optionally concentrating the casein concentrate material,    -   c) heat-treating the material,    -   d) cooling the heat-treated material,    -   e) subjecting the cooled material to a treatment with a        crosslinking enzyme,    -   f) optionally subjecting the cooled material to a treatment with        a coagulant,    -   g) processing into a casein protein product/allowing a casein        protein product to form,    -   h) optionally collecting and/or packing the product.

In one embodiment, the casein concentrate material is treated with acrosslinking enzyme and with a coagulant to produce a casein proteinproduct having microstructure similar to a meat analogue. Accordingly,the invention relates to a process for producing a casein proteinproduct, comprising the steps of:

-   -   a) providing a casein concentrate starting material,    -   b) optionally concentrating the casein concentrate material,    -   c) heat-treating the material,    -   d) cooling the heat-treated material,    -   e) subjecting the cooled material to a treatment with a        crosslinking enzyme,    -   f) subjecting the cooled material to a treatment with a        coagulant,    -   g) processing into a casein protein product/allowing a casein        protein product to form,    -   h) optionally collecting and/or packing the product.

Casein concentrate starting material refers to a casein concentratecomprising casein as the main milk protein component, lactose, calciumions, phosphate ions and only minor amounts of whey protein. In oneembodiment, the casein concentrate contains about 9-about 12 weight-%milk proteins of which 0-about 0.5 weight-% are whey proteins. In acertain embodiment, the casein concentrate contains about 8-about 11weight-% caseins. In a certain embodiment, the casein concentratecontains about 9.15 weight-% milk proteins of which about 8.5 weight-%are caseins and about 0.2 weight-% are whey proteins.

In one embodiment, the casein concentrate can be obtained from a milkraw material by a membrane filtration procedure comprisingmicrofiltration, ultrafiltration, nanofiltration, reverse osmosis and/orevaporation.

Accordingly, the present invention relates to a process for producing acasein protein product, comprising the steps of:

-   -   a) providing a milk raw material,    -   b) subjecting the milk raw material to membrane filtration        procedure to produce a casein concentrate,    -   c) optionally concentrating the casein concentrate,    -   d) heat-treating the casein concentrate,    -   e) cooling the heat-treated material,    -   f) optionally subjecting the cooled material to a treatment with        a crosslinking enzyme,    -   g) subjecting the cooled material to a treatment with a        coagulant,    -   h) processing the material into the casein protein product,    -   i) optionally collecting and/or packing the product.

In another embodiment, the casein concentrate starting material can beobtained from a caseinate.

Accordingly, the present invention relates to a process for producing acasein protein product, comprising the steps of:

-   -   a) providing casein concentrate based on a caseinate,    -   b) optionally concentrating the casein concentrate,    -   c) heat-treating the casein concentrate,    -   d) cooling the heat-treated material,    -   e) subjecting the cooled material to a treatment with a        crosslinking enzyme,    -   f) optionally subjecting the cooled material to a treatment with        a coagulant,    -   g) processing the material into the casein protein product,    -   h) optionally isolating and/or packing the product.

In the heat-treatment step, the casein concentrate is heated up to atemperature of at least 80° C. In one embodiment, the casein concentrateis heated up to a temperature from 80° C. to 155° C. In anotherembodiment, the casein concentrate is heated up to a temperature of 80°C. Further, in one embodiment, the casein concentrate is kept in atemperature of at least 80° C. for 5 to 30 minutes.

In the cooling step, the casein concentrate is allowed to cool or iscooled to a temperature below 40° C. In one embodiment, the caseinconcentrate is allowed to cool or is cooled to a temperature from 2° C.to 20° C. In another embodiment, the casein concentrate is allowed tocool or is cooled to a temperature from 2° C. to 10° C.

In the step of treating with a crosslinking enzyme, the caseinconcentrate is modified with a crosslinking enzyme. The crosslinkingenzyme suitable for use in the process of the invention may be anyenzyme that is known to crosslink milk proteins. These enzymes includetransglutaminase, laccase, tyrosinase, peroxidase, sulfhydryl oxidase,glucose oxidase and protein glutaminase, for example. Said enzymes canbe used alone or in any combinations with each other. The enzyme istypically used in an amount of 0.2 U enzyme/g protein to about 20 Uenzyme/g protein, preferably about 3U enzyme/g protein.

In an embodiment of the invention, the crosslinking enzyme istransglutaminase (EC 2.3.2.13). It is commonly known thattransglutaminase catalyzes the generation of covalent linkages betweenthe glutamine and lysine amino acid residues present in the proteinmolecules. Of milk proteins, caseins, in particular K-casein, are thebest substrates for a transglutaminase. β-casein, too, is rich inglutamine and lysine that the enzyme links together. Transglutaminasecan be any transglutaminase commonly used in dairy industry. It can bederived from a microbial source, fungus, mould, fish and a mammal. In anembodiment of the invention, transglutaminase is isolated from amicrobial source. There are several commercially availabletransglutaminase enzyme preparations that are suitable for use in theprocess of the invention. These include Activa®YG (Ajinomoto, Japan),Activa®MP (Ajinomoto, Japan), and Yiming-TG (Yiming Fine Chemicals Co.,Ltd., China). Optimum conditions depend on the enzyme used and they canbe obtained from the manufacturers of the commercial enzymes.

In another embodiment, the crosslinking enzyme is selected from laccase,tyrosinase, peroxidase, sulfhydryl oxidase, glucose oxidase and/orprotein glutaminase. Laccases (EC 1.10.3.2) derived from fungi andbacteria, such as, fungus Trametes hirsute, catalyze the crosslinkingbetween carbohydrates and proteins (oxidation of aromatic compounds andcysteine) with applications in food processing for reduction ofallergenicity, for example. Tyrosinases (EC 1.14.18.1) are enzymes whichcatalyzes the oxidation of phenols such as tyrosine, with applicationsin food processing for reduction of allergenicity, for example.Tyrosinases can be derived from a variety of plant, animal and fungalspecies, i.e. filamentous fungus Trichoderma reesei. Peroxidases (EC1.11.1.7) are a family of enzymes that catalyze the oxidation ofaromatic compounds with applications in food processing for reduction ofallergenicity, for example. Sulfhydryl oxidase (EC 1.8.3.3) catalyzesthe formation of disulfide bonds, oxidation of glutathione. Glucoseoxidase catalyzes the formation of protein crosslinks and oxidategelation of pentosans. Protein glutaminase (PG) catalyzes thedeamidation of protein bound glutamine, and glutamine is converted toglutamic acid.

In the step of treating with a coagulant, the casein concentrate ismodified with an agent generating coagulation or simultaneous clottingand gel forming in the material. Suitable agents are acidifiers orferment like starters, acids and acidogens, such as gluconodelta-lactone (GDL), lactic acid, citric acid, hydrochloric acid, oxalicacid, and coagulants, like rennet and chymosin, and calcium salts. Inone embodiment, the agent is rennet or chymosin. Chymosin is the activeenzyme in rennet. Chymosin cleavages the peptide bond between 105 and106, phenylalanine and methionine, in kappa-casein. Coagulant is used ina sufficient amount. The chymosin enzyme is typically used in an amountfrom about 0.0001% to about 0.05%, preferably about 0.002%.

Crosslinking enzyme treatment and coagulation treatment of the caseinconcentrate can be done simultaneously or sequentially in either order.In one embodiment, crosslinking enzyme treatment and coagulation aredone simultaneously. In another embodiment, crosslinking enzymetreatment is done first followed by coagulation. In a furtherembodiment, coagulation is done first followed by crosslinking enzymetreatment. In a preferred embodiment, crosslinking enzyme treatment andcoagulation are done simultaneously. In another preferred embodiment,coagulation is done first followed by crosslinking enzyme treatment. Inaddition, in one embodiment the temperature during the treatment with acrosslinking enzyme and coagulation is in the range of about 2° C. toabout 20° C. In another embodiment the temperature during crosslinkingenzyme treatment and coagulation is in the range of about 2° C. to about10° C. It is important that the whey does not separate during thecrosslinking enzyme and coagulation treatment(s).

In the present invention, the casein concentrate material can beproduced by membrane filtration of a milk raw material.

For fractionation of casein from milk raw material, filtrationtechniques, such as microfiltration, ultrafiltration, nanofiltration,reverse osmosis or their combinations, can be used.

The membrane filtrations, such as ultrafiltration and microfiltration,can be performed with diafiltration technique.

Microfiltration of the milk raw material is performed in such a mannerthat the milk raw material is concentrated by a factor of 1 to 4.5 timesby volume, preferably 3.5 to 4.5 times by volume. The concentrationfactor (cf=K) refers to the ratio of the volume of the liquid fed to thefiltration to the retentate, and it is defined with the followingformula: K=feed (L)/retentate (L) (L=volume). The concentration factorof ultrafiltration is typically in the range of 1 to 10. In anembodiment, the concentration coefficient is 2 to 5. In one embodiment,the microfiltration is performed in a temperature below 20° C. Inanother embodiment the microfiltration is performed in a temperaturerange of 2° C. to 20° C. In a further embodiment the temperature duringmicrofiltration is in the range of 10° C. to 14° C.

The microfiltration of the milk raw material retains major portion ofthe casein in the retentate whereas a major portion of the whey proteinspasses into the permeate. The microfiltration is preferably carried oututilizing a uniform transmembrane pressure loop recirculating theretentate through membrane and permeate through permeate site ofmembrane.

The microfiltration may comprise a plurality of microfiltration steps.Different steps may comprise, for instance, changing of processconditions and/or filtration membranes. A variable condition may be, forinstance, filtration temperature, filtration pressure, addition ofdiafiltration medium (diawater), and/or concentration factor offiltration. Conditions can be changed by one or more variables. In themicrofiltration comprising a plurality of microfiltration steps, morethan one MF permeate and retentate fractions may be formed.

In one embodiment, the casein concentrate is obtained using acombination of microfiltration, ultrafiltration, nanofiltration andreverse osmosis.

In an embodiment, raw material milk is subjected to a membranefiltration in order to provide a casein concentrate for furthertreatment with a protein crosslinking enzyme and a coagulant. In themembrane filtration, substances inhibiting the activity of a proteincrosslinking enzyme are passed into a permeate while casein protein isconcentrated in the retentate. The membrane filtration is preferablycarried out, since the substances inhibiting a protein crosslinkingenzyme are removed and the enzyme can act actively. Thus, a largerproportion of the milk proteins can be treated with the sametransglutaminase amount resulting in increased yields of the caseinprotein product.

In the context of the present invention, the milk raw material refers towhole milk, cream, low-fat or skim milk, low-lactose or lactose-freemilk, or milk reconstituted from milk powder, organic milk or acombination of these. Preferably, the milk raw material is skim milk.The milk raw material may be supplemented by ingredients generally usedin producing milk products, such as fat or sugar fractions.

The membrane filtration of the milk raw material provides a caseinconcentrate starting material containing casein, lactose, and calcium-and phosphate-ions. In one embodiment, the membrane filtration of themilk raw material provides a casein concentrate containing milk proteinsabout 9-about 50 weight-%, of which about 8.5-about 50 weight-% arecaseins, lactose 0-about 2 weight-%, calcium about 2500-about 12500mg/kg, phosphorus about 1600-about 8000 mg/kg. In one embodiment, themilk protein content is in the range of about 15-about 30 weight-%, ofwhich about 14.5-about 50 weight-% are caseins. In another embodiment,the calcium content is in the range of about 4000-about 7000 mg/kg,preferably in the range of about 3000-about 5000 mg/kg. In a furtherembodiment, the calcium content is about 3200 mg/kg. In an even furtherembodiment, the casein concentrate contains about 9.15 weight-% milkproteins of which about 8.5 weight-% are caseins and about 0.2 weight-%are whey proteins. In a certain embodiment of the present invention, themembrane filtration of the milk raw material provides a caseinconcentrate containing milk proteins 9-50 weight-%, of which 8.5-50weight-% are caseins, lactose 0-0.2 weight-%, calcium 2500-12500 mg/kg,phosphorus 1600-8000 mg/kg. In a certain embodiment, the milk proteincontent is in the range of 15-30 weight%, of which 14.5-50 weight-% arecaseins. In a certain embodiment, the calcium content is in the range of4000-7000 mg/kg, preferably in the range of 3000-5000 mg/kg. In acertain embodiment, the calcium content is 3200 mg/kg. In a certainembodiment, the casein concentrate contains 9.15 weight-% milk proteinsof which 8.5 weight-% are caseins and 0.2 weight-% are whey proteins.

In the present invention, the casein concentrate material can be derivedand/or produced from micellar casein, acid casein, hydrolyzed casein orrennet casein, for example. Micellar casein is ultrafiltered caseinextracted from milk without acidification. Acid casein is a dry freeflowing high quality protein food ingredient that has been isolated fromskim milk. Hydrolysed casein is a soluble, enzymatic digest of casein.Rennet casein is produced by the controlled precipitation of casein frompure, pasteurized skim milk through the action of rennet.

In the present invention, the casein concentrate starting material canbe obtained from caseinate. Caseinates, such as sodium caseinate,calcium caseinate and potassium caseinate, are soluble salts of casein.Caseinates provide outstanding nutritional properties, contain all ofthe essential amino acids, have a protein efficiency ratio (P.E.R.) of2.5, and have a minimum protein content of 90% (dry solids basis). Inone embodiment, the casein material/casein concentrate can be obtainedfrom calcium caseinate.

In the present invention, casein concentrate material can be can besupplemented with milk minerals. A milk mineral refers to, for example,a salt described in publication EP 1061811 B1, i.e. a milk mineralpowder known as trademark Valio Milk Mineral Powder VMMP (Valio Oy).Other feasible milkbased mineral products include such trademarks asCapolac® MM-0525 BG (Arla Foods Ingredients), Vitalarmor CA (ArmorProteins) and Sodidiet 40 MI (Sodiaal Industrie).

The casein concentrate of the present invention comprises casein as themain milk protein component, lactose, and calcium- and phosphate-ions.The casein concentrate of the present invention may contain minoramounts of whey protein(s). Typically, the casein concentrate compriseswhey proteins up to about 0.5 weight-%, at the maximum. If the caseinconcentrate of the present invention contains whey proteins in higheramounts, or in or up to the amount typical to cow's milk i.e., up to orin the casein:whey ratio of about 80:20, the structure of the caseinprotein product produced from such concentrate would not be strong for ameat substitute, for example. In one embodiment, the casein concentratecomprises milk proteins about 9-about 50 weight-% of which 0-about 0.5weight-% are whey proteins and about 8.5-about 50 weight-% are caseins,lactose 0-about 2 weight-%, calcium about 2500 mg/kg-about 12500 mg/kgand phosphorus about 1600-about 8000 mg/kg. In one embodiment, the milkprotein content is in the range of about 15-about 30 weight-% of which0-about 0.5% are whey proteins and about 14.5-about 50 weight-% arecaseins. In another embodiment, the calcium content is in the range ofabout 4000-about 7000 mg/kg, preferably in the range of about 3000-about5000 mg/kg. In a further embodiment, the calcium content is about 3200mg/kg. In another embodiment, the casein concentrate is concentrated byevaporation to contain from about 9 to about 50 weight-% casein. Inanother embodiment casein powder is reconstituted to solution havingcasein content of about 9-about 50 weight-%. In an even furtherembodiment, the casein concentrate contains about 9.15 weight-% milkproteins of which about 8.5 weight-% are caseins and about 0.2 weight-%are whey proteins. In a certain embodiment, the casein concentratecomprises milk proteins 9-50 weight-% of which 0-0.5 weight% are wheyproteins and 8.5-50 weight-% are caseins, lactose 0-2 weight-%, calcium2500 mg/kg 12500 mg/kg and phosphorus 1600-8000 mg/kg. In oneembodiment, the milk protein content is in the range of 15-30 weight-%of which 0-0.5% are whey proteins and 14.5-50 weight-% are caseins. Inanother embodiment, the calcium content is in the range of 4000-7000mg/kg, preferably in the range of 3000-5000 mg/kg. In a furtherembodiment, the calcium content is 3200 mg/kg. In another embodiment,the casein concentrate is concentrated by evaporation to contain 9-50weight-% casein. In another embodiment, casein powder is reconstitutedto solution having casein content of 9-50 weight-%. In a certainembodiment, the casein concentrate contains 9.15 weight-% milk proteinsof which 8.5 weight-% are caseins and 0.2 weight-% are whey proteins. Ina certain embodiment, the casein concentrate contains caseins about8.5-about weight-11%, whey proteins about 0.2-about 0.5 weight-%,lactose about 0.4-about 1.0 weight-%, calcium about 2500 to about 4000mg/kg, phosphorus about 1600 to about 2000 mg/kg, magnesium about 130 toabout 150 mg/kg, sodium about 86 to about 100 mg/kg and potassium about340 to about 500 mg/kg.

In one embodiment, the present invention relates to a process forproducing a casein protein product, comprising the steps of:

-   -   a) providing casein concentrate comprising milk proteins about        9-about 50 weight-%, of which about 8.5-about 50 weight-% are        caseins,    -   b) optionally concentrating the casein concentrate,    -   c) heat-treating the casein concentrate to a temperature from        80° C. to 155° C.,    -   d) cooling the heat-treated material to a temperature from 2° C.        to 20° C.,    -   e) subjecting the cooled material to a treatment with a        transglutaminase enzyme,    -   f) optionally subjecting the cooled material to a treatment with        a rennet and/or chymosin,    -   g) processing the material into the casein protein product,    -   h) optionally isolating and/or packing the product.

In another embodiment, the present invention relates to a process forproducing a casein protein product, comprising the steps of:

-   -   a) providing casein concentrate comprising milk proteins about        9-about 50 weight-%, of which about 8.5-about 50 weight-% are        caseins, lactose 0-about 2 weight-%, calcium about 2500-about        12500 mg/kg and phosphorus about 1600-about 8000 mg/kg,    -   b) optionally concentrating the casein concentrate,    -   c) heat-treating the casein concentrate to a temperature from        80° C. to 155° C.,    -   d) cooling the heat-treated material to a temperature from 2° C.        to 20° C.,    -   e) subjecting the cooled material to a treatment with a        transglutaminase enzyme,    -   f) optionally subjecting the cooled material to a treatment with        a rennet and/or chymosin,    -   g) processing the material into the casein protein product,    -   h) optionally isolating and/or packing the product.

In a further embodiment, the present invention relates to a process forproducing a casein protein product, comprising the steps of:

-   -   a) providing casein concentrate comprising milk protein milk        proteins about 15-about 30 weight-%, of which about 14.5-about        30 weight-% are caseins,    -   b) optionally concentrating the casein concentrate,    -   c) heat-treating the casein concentrate to a temperature from        80° C. to 155° C.,    -   d) cooling the heat-treated material to a temperature from 2° C.        to 20° C.,    -   e) subjecting the cooled material to a treatment with a        transglutaminase enzyme,    -   f) optionally subjecting the cooled material to a treatment with        a rennet and/or chymosin,    -   g) processing the material into the casein protein product,    -   h) optionally isolating and/or packing the product.

The process of the invention may further contain additional optionalprocess steps, such as homogenisation and/or a further-processing stepin which the casein concentrate based material is treated in a mannerrequired by the product being prepared, for instance by addingingredients, mixing and/or recovering the product in a mannercharacteristic to it. These optional steps are performed in anappropriate stage of the process known by a person skilled in the art.The selection of suitable optional steps and conditions belongs toknowledge of a person skilled in the art.

The invention relates also to a casein protein product produced with themethod described herein.

In addition, the present invention relates also to a casein proteinproduct comprising milk proteins about 9-about 50 weight-%, of whichabout 8.5-about 50 weight-% are caseins and 0-about 0.5 weight-% arewhey proteins. In one embodiment, the casein protein product furthercomprises lactose from 0-about 2 weight-%, calcium from about 1300 toabout 12500 mg/kg, phosphorus from about 1600 to about 8000 mg/kg andoptionally biologically active peptides (tripeptides IPP and/or VPP)from about 20 to about 700 mg/kg. In one embodiment, the casein proteinproduct comprises milk proteins about 15-about 30 weight-%, of whichabout 14.5-about 30 weight-% are caseins. In another embodiment, thecalcium content is in the range of about 4000-about 7000 mg/kg,preferably in the range of about 3000-about 5000 mg/kg. In a furtherembodiment, the calcium content is about 3200 mg/kg. In an even furtherembodiment, the casein protein product contains about 9.15 weight-% milkproteins of which about 8.5 weight-% are caseins and about 0.2 weight-%are whey proteins. In a certain embodiment, the casein protein productcontains milk proteins 9-50 weight-%, of which 8.5-50 weight-% arecaseins. In a certain embodiment, the casein protein product furthercomprises, lactose 0-0.2 weight-%, calcium 2500-12500 mg/kg, phosphorus1600-8000 mg/kg. In a certain embodiment, the milk protein content ofthe casein protein product is in the range of 15-30 weight-%, of which14.5-30 weight-% are caseins. In a certain embodiment, the calciumcontent is in the range of 4000-7000 mg/kg, preferably in the range of3000-5000 mg/kg. In a certain embodiment, the calcium content is 3200mg/kg. In a certain embodiment, the casein protein product contains 9.15weight-% milk proteins of which 8.5 weight-% are caseins and 0.2weight-% are whey proteins. In a certain embodiment, the casein proteinproduct comprises milk proteins about 9-about 50 weight-%, of whichabout 8.5-about 50 weight% are caseins and 0-about 0.5 weight-% are wheyproteins, lactose from 0-about 2 weight-%, calcium from about 1300 toabout 12500 mg/kg, phosphorus from about 1600 to about 8000 mg/kg andbiologically active peptides (tripeptides IPP and/or VPP) from about 20to about 700 mg/kg.

If the casein protein product of the present invention contains wheyproteins in higher amounts, or up to or in the amount typical to cow'smilk i.e., up to or in the casein:whey ratio of about 80:20, the productwould not have a microstructure similar to a meat analogue andaccordingly the texture of the product would not be strong enough for ameat substitute. In addition, lactose, which is typically included inthe whey protein fraction, makes the product sweet and further when wheyproteins are heated, the flavor of cooked milk is formed in the product.Accordingly, it is critical for the casein protein product of thepresent invention, that the amount of whey proteins in the product islow (about 0.5. weight-% at the maximum).

Additionally, the casein protein product may comprise fats and/or oils,such as palm oil, rape and rapeseed oil, linseed oil, olive oil, cornoil, sunflower oil, cream, butter oil or combinations or mixturesthereof. The milk protein product of the present invention has pH in therange of 5.5 to 6.7.

The casein protein product may also comprise hydrocolloids and/orpolysaccharides such as alginates, pectins, carrageenan, locust beangum, guar gum, gellan gum, xanthan gum, acacia gum, carob, beta-glucan,arabinoxylan, carboxymethyl cellulose (CMC), polydextrose, bacterialexopolysaccharides and starches derived from potato, maize, pea, rice,wheat, tapioca and durra, for example.

The casein protein product of the present invention can beseasoned/flavoured by adding desired spices and/or herbs to the caseinmaterial during the manufacturing process or by adding the desiredspices and/or herbs to the inner surface of the moulding tube or to thecasein protein base during the processing of the material into thecasein protein product.

The casein protein product of the present invention can be used as ameat substitute/meat analogue eaten as such, heated, cooked, fried orgrilled like meat.

The following examples are presented to further illustration of theinvention without limiting the invention thereto.

EXAMPLE 1

A casein concentrate (2000 L) obtained from microfiltration and having acasein content of at least 9 weight-% was heated up to a temperatureabove 80° C. The casein solution was allowed to cool to a temperature of40° C. and it was dispensed in moulds. Transglutaminase (1 U/g protein)and chymosin enzymes (0.0001%) were added to the solution and the caseinprotein product was allowed to form by coagulation in the roomtemperature.

Casein protein product: protein 10 weight-%, lactose 0.9 weight-%,calcium 2500 mg/kg, phosphorus 1600 mg/kg and biologically activepeptides 300 mg/kg.

EXAMPLE 2

A filtered casein solution (2000 L) was concentrated at 90° C. byevaporating.

The concentrated solution (1000 L) was cooled to a temperature below 10°C. and transglutaminase and chymosin enzymes were added. The solutionwas dispensed into so-called moulding tube having a flavoring mixtureintegrated into its inner surface. The casein solution was allowed tocoagulate in the tube in the room temperature. The milk protein productin tube was cooled to a temperature of +2° C. to +4° C. The formedcasein protein product was cut into pieces or slices of desiredthickness which were packed with an inert gas.

Casein protein product: protein 19 weight-%, lactose 0.3 weight-%,calcium 5000 mg/kg, phosphorus 3200 mg/kg and biologically activepeptides 400 mg/kg.

EXAMPLE 3

Skim milk was microfiltered to a casein solution (2000 L) which wasfurther concentrated by ultrafiltration (concentration factor 2-3) tocasein concentrate (15-20 weight-% protein). The concentrated solution(700-1000 L) was heated up to a temperature of 80° C.-150° C. Then thesolution was cooled to a temperature below 10° C. and chymosin andtransglutaminase were added thereto and the casein protein product wasallowed to form by coagulation in the room temperature.

Casein protein product: protein 19-30 weight-%, lactose 0.8-1.2weight-%, calcium 5000-8000 mg/kg, phosphorus 3000-4200 mg/kg andbiologically active peptides 500-650 mg/kg.

EXAMPLE 4

Casein in powder form was reconstituted in water or in a concentratedfiltration solution described in Example 1 or in Example 2 to give asolution having protein content of 20-50 weight-%.

The solution was heated up to a temperature of 80° C.-150° C. Then thesolution was cooled to a temperature below 10° C. and chymosin andtransglutaminase were added thereto. The solution was dispensed intoso-called moulding tube having a flavoring mixture integrated into itsinner surface and allowed to coagulate in the tube in the roomtemperature. The casein protein product in tube was cooled to atemperature of +2° C. to +4° C. The formed milk protein product was cutinto pieces or slices of desired thickness which were packed with aninert gas.

Casein protein product: protein 50 weight-%, lactose 1.5 weight-%,calcium 12300 mg/kg, phosphorus 5000 mg/kg and biologically activepeptides 650 mg/kg.

EXAMPLE 5

A filtered casein solution was heated up to a temperature above 80° C.The solution was cooled to a temperature of 40° C. and then chymosin wasadded to the casein solution. The solution was dried into a powder whichwas reconstituted in water to give a solution having protein content of20-50% and heated up to a temperature above 80° C. The solution wascooled to a temperature below 10° C. and transglutaminase was addedthereto. The solution was dispensed into a so-called moulding tubehaving a flavoring mixture integrated into its inner surface. The caseinsolution was allowed to coagulate in the tube in the room temperature.The milk protein production tube was cooled to a temperature of +2° C.to +4° C. The formed casein protein product was cut into pieces orslices of desired thickness which were packed with an inert gas.

Casein protein product: protein 47 weight-%, lactose 1 weight-%, calcium10000 mg/kg, phosphorus 3500 mg/kg and biologically active peptides 500mg/kg.

EXAMPLE 6

Casein concentrate was produced as follows: raw milk was skimmed andpasteurized at 73° C. for 15 s. The resultant pasteurized skim milk wassubjected to microfiltration (MF) and recirculated through membranes ofa pore size 0.08 μm at a temperature of 13° C. to concentrate casein ina MF retentate. Water, a major portion of whey protein and part of thelactose and milk minerals passed through the membrane to a permeate.Casein retentate (i.e. casein concentrate) having the total solids ofabout 9 weight-% to 12 weight-% was optionally further processed tohigher dry weight by evaporation or spray drying (or freeze drying) tothe total solids of 20 weight-% up to 95 weight-%.

The composition of the casein retentate/casein concentrate (total solidsof about 9 to about 12 weight-%) is:

Casein about 8.5 to 11 weight-%

Whey protein about 0.2 to 0.5 weight-%

Lactose about 0.4 to 1.0 weight-%

Calcium about 2500 to 4000 mg/kg

Phosphorus about 1600 to 2000 mg/kg

Magnesium about 130 to 150 mg/kg

Sodium about 86 to 100 mg/kg

Potassium about 340 to 500 mg/kg.

It will be obvious to a person skilled in the art that, as thetechnology advances, the inventive concept can be implemented in variousways. The invention and its embodiments are not limited to the examplesdescribed above but may vary within the scope of the claims.

1. A casein protein product, comprising milk proteins 9-50 weight-%wherein 8.5-50 weight-% of the casein protein product are caseins and0-0.5 weight-% of the casein protein product are whey proteins, andhaving pH in the range of 5.5 to 6.7.
 2. The casein protein product ofclaim 1, wherein the product comprises milk proteins 15-30 weight-%,wherein 14.5-30 weight-% of the casein protein product are caseins and0-0.5 weight-% of the casein protein product are whey proteins.
 3. Thecasein protein product of claim 1, wherein the product comprises milkproteins 9-12 weight-% wherein 0-0.5 weight-% of the casein proteinproduct are whey proteins.
 4. The casein protein product of claim 1,wherein the product comprises transglutaminase-treated casein.
 5. Thecasein protein product of claim 1, wherein the product further compriseslactose 0-2 weight-%.
 6. The casein protein product of claim 1, whereinthe product comprises calcium 1300-12500 mg/kg.
 7. The casein proteinproduct of claim 1, wherein the product comprises calcium 2500-12500mg/kg.
 8. The casein protein product of claim 1, wherein the productcomprises calcium 4000-7000 mg/kg.
 9. The casein protein product ofclaim 1, wherein the product comprises calcium 3000-5000 mg/kg.
 10. Thecasein protein product of claim 1, wherein the product comprises calcium2500-4000 mg/kg.
 11. The casein protein product of claim 1, wherein theproduct comprises phosphorus 1600-8000 mg/kg.
 12. The casein proteinproduct of claim 1, wherein the product comprises phosphorus 3000-5000mg/kg.
 13. The casein protein product of claim 1, wherein the productcomprises phosphorus 1600-2000 mg/kg.
 14. The casein protein product ofclaim 1, wherein the product comprises biologically active peptides20-700 mg/kg.
 15. The casein protein product of claim 1, wherein theproduct comprises fats and/or oils, such as palm oil, rape and rapeseedoil, linseed oil, olive oil, corn oil, sunflower oil, cream, butter oilor combinations or mixtures thereof.
 16. The casein protein product ofclaim 1, wherein the product is a meat substitute.
 17. The caseinprotein product of claim 1, wherein the product is produced by a methodcomprising the steps of: a) providing a casein concentrate startingmaterial, wherein the casein concentrate starting material comprisesmilk proteins 9-50 weight-%, and wherein 8.5-50 weight-% of the caseinconcentrate starting material are caseins, b) optionally concentratingthe casein concentrate material, c) heat-treating the material up to atemperature from 80° C. to 155° C., d) cooling the heat-treatedmaterial, e) subjecting the cooled material to a treatment with acrosslinking enzyme, f) optionally subjecting the cooled material to atreatment with a coagulant, g) processing the material into the caseinprotein product having a pH in the range of 5.5 to 6.7, and h)optionally isolating and/or packing the product.